Immunochemotherapy and AlloSCT in Patients With High Risk CD33+ AML/MDS
Clinical trial NCT02221310 · COMPLETED
Trial details
- NCT number
- NCT02221310
- Sponsor
- New York Medical College
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-07
- Primary completion
- 2023-04-04
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.